Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U2 small nuclear 9, pseudogene (RNU2-9P)
- Target
- RNU2-9P
- Molecular classification
- Other (Pseudogene), Small nuclear RNA (non-coding RNA, snRNA; as family, not specific to this pseudogene)
01
Overview
RNA, U2 small nuclear 9, pseudogene (RNU2-9P) is a pseudogene of the U2 small nuclear RNA (snRNA) family. U2 snRNAs are essential, highly conserved, small non-coding RNAs that play a crucial role in the spliceosome complex, mediating pre-mRNA splicing. However, RNU2-9P itself is a non-functional genomic copy (pseudogene) and does not encode a mature, functional RNA product. Pseudogenes like RNU2-9P are generally not transcribed or functional and do not contribute to biological processes or disease directly. They are not considered therapeutic targets, have no known roles in disease, and do not interact with drugs.
- Other names
- RNU2-9PRNA, U2 small nuclear 9, pseudogene
02
Mechanism of action
Not applicable
03
Biological functions
None assigned (pseudogene)For reference, U2 snRNA (functional gene) participates in pre-mRNA splicing as a core component of the spliceosome, but pseudogenes like RNU2-9P are not believed to be functionally active
04
Disease associations
None known for this pseudogeneFunctional U2 snRNA genes have been associated with neurodevelopmental disorders when mutated, but this does not apply to pseudogenes like RNU2-9P
05
Safety considerations
None known
06
Interacting drugs
None known
07
Biomarkers
None known
Beyond the preview
Go deeper on RNA, U2 small nuclear 9, pseudogene (RNU2-9P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U2 small nuclear 9, pseudogene (RNU2-9P).